Abstract
Dissecting how bacterial pathogens escape immune destruction and cause respiratory infections in humans is a work in progress. One tactic employed by microbes is to use bacterial adenylate cyclase toxins (ACTs) to disarm immune cells and disrupt cellular signaling in host cells, which facilitates the infection process. Several clinically significant pathogens, such as Bacillus anthracis and Bordetella pertussis, have ACTs that are stimulated by an activator protein in human cells. Research has shown that these bacterial ACTs have evolved distinct ways of controlling their activities, but our understanding of how the B. pertussis ACT does this is limited. In a recent study, O'Brien and colleagues provide new and exciting evidence demonstrating that the regulation of B. pertussis ACT involves conformational switching between flexible and rigid states, which is triggered upon binding the host activator protein. This study increases our knowledge of how bacterial ACTs are unique enzymes, representing a potentially novel class of drug targets that may open new pathways to combat reemerging infectious diseases.
References
Dec 1, 1989·Infection and Immunity·A A Weiss, M S Goodwin
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J WolffS A Berkowitz
Apr 28, 1999·Trends in Microbiology·D Ladant, A Ullmann
Nov 18, 2000·Infection and Immunity·C L WeingartA A Weiss
Jan 25, 2002·Nature·Chester L DrumWei-Jen Tang
Dec 18, 2002·The EMBO Journal·Yuequan ShenWei-Jen Tang
May 2, 2003·The Journal of Biological Chemistry·Tobias S UlmerAd Bax
Sep 3, 2005·The EMBO Journal·Qing GuoWei-Jen Tang
Jun 28, 2008·The Journal of Biological Chemistry·Qing GuoWei-Jen Tang
Nov 22, 2011·Journal of Molecular Biology·Julie Rumi-MasanteTrevor P Creamer
May 27, 2014·Journal of Molecular Biology·Alvaro VillarroelPilar Areso
Jun 8, 2014·The Journal of Biological Chemistry·Edithe SelwaThérèse E Malliavin
Sep 19, 2014·The Journal of Biological Chemistry·Johanna C KarstAlexandre Chenal
Sep 25, 2014·Biochemical and Biophysical Research Communications·Tzvia I SpringerNatosha L Finley
Sep 26, 2015·PloS One·Ying YangYonghong Yang
Jan 18, 2017·FEBS Open Bio·Tzvia I SpringerNatosha L Finley
Feb 12, 2017·Scientific Reports·Sara E CannellaAlexandre Chenal
Jul 5, 2017·Toxins·Thérèse E Malliavin
Sep 28, 2017·Toxins·Jakub NovakRadim Osicka
Dec 1, 2017·Toxins·Christian W Johns, Natosha L Finley
Dec 30, 2017·PLoS Biology·Darragh P O'BrienAlexandre Chenal